| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2018-04-13 |
详情>>
股本变动：
变动后总股本7387.16万股
|
| 2018-03-01 |
财报披露：
美东时间 2018-03-01 盘前发布财报
|
| 2018-03-01 |
详情>>
业绩披露：
2017年年报每股收益-6.53美元,归母净利润-4.69亿美元,同比去年增长0.58%
|
| 2018-02-12 |
股东大会：
将于2018-03-27召开股东大会
会议内容 ▼▲
- 1. To consider and vote upon a proposal to adopt the Business Combination Agreement, dated as of October 17, 2017 (the “BCA”), by and among Amneal Pharmaceuticals LLC (“Amneal”), Atlas Holdings, Inc. (“Holdco”), K2 Merger Sub Corporation (“Merger Sub”) and Impax, as amended on November 21, 2017 and December 16, 2017, and thereby approve the transactions contemplated thereby (the “Combination Proposal”);
2. To consider and vote upon a proposal to approve, on a non-binding advisory basis, certain compensatory arrangements between Impax and certain named Impax executive officers relating to the Combination that are described in the section entitled “The Special Meeting—Vote Required and Impax Board Recommendation—Compensation Proposal” beginning on page 68 of the enclosed combined proxy statement/prospectus (the “Compensation Proposal”);
3. To consider and vote upon a proposal to approve and adopt the Atlas Holdings, Inc. 2018 Incentive Award Plan;
4. To consider and vote upon a proposal to approve any proposal to adjourn the Special Meeting, or any postponement thereof, to another time or place if necessary or appropriate (i) due to the absence of a quorum at the Special Meeting, (ii) to prevent a violation of applicable law, (iii) to provide to Impax Stockholders any supplement or amendment to the combined proxy statement/prospectus and/or (iv) to solicit additional proxies if Impax reasonably determines that it is advisable or necessary to do so in order to obtain Impax Stockholder approval of the Combination Proposal.
|
| 2017-11-09 |
财报披露：
美东时间 2017-11-09 盘前发布财报
|
| 2017-11-09 |
详情>>
业绩披露：
2017年三季报(累计)每股收益-2.34美元,归母净利润-1.68亿美元,同比去年增长12.59%
|
| 2017-10-17 |
复牌提示：
2017-10-17 07:24:26 停牌，复牌日期 2017-10-17 08:00:00
|
| 2017-08-09 |
财报披露：
美东时间 2017-08-09 盘前发布财报
|
| 2017-08-09 |
详情>>
业绩披露：
2017年中报每股收益-1.66美元,归母净利润-1.19亿美元,同比去年增长-806.61%
|
| 2017-05-10 |
详情>>
业绩披露：
2017年一季报每股收益-1.37美元,归母净利润-9843.1万美元,同比去年增长-845.72%
|
| 2017-04-05 |
股东大会：
将于2017-05-16召开股东大会
会议内容 ▼▲
- (i)to elect nine directors named in the accompanying proxy statement;
(ii)to approve the Amendment and Restatement of our Non-Qualified Employee Stock Purchase Plan to, among other items, increase the aggregate number of shares of our common stock reserved under such plan by 1,500,000 shares;
(iii)to approve the Fourth Amendment and Restatement of our 2002 Equity Incentive Plan to, among other items, increase the aggregate number of shares of our common stock that may be issued under such plan by 2,100,000 shares;
(iv)to hold an advisory vote to approve named executive officer compensation (“say-on-pay”);
(v)to hold an advisory vote on the frequency of say-on-pay votes;
(vi)to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
(vii)to transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2017-03-01 |
详情>>
业绩披露：
2016年年报每股收益-6.63美元,归母净利润-4.72亿美元,同比去年增长-1310.43%
|
| 2017-03-01 |
详情>>
业绩披露：
2014年年报每股收益0.84美元,归母净利润5735.30万美元,同比去年增长-43.36%
|
| 2016-11-09 |
详情>>
业绩披露：
2016年三季报(累计)每股收益-2.71美元,归母净利润-1.92亿美元,同比去年增长-798.03%
|
| 2016-11-09 |
详情>>
业绩披露：
2015年三季报(累计)每股收益0.40美元,归母净利润2757.00万美元,同比去年增长-51.83%
|
| 2016-08-09 |
详情>>
业绩披露：
2016年中报每股收益-0.18美元,归母净利润-1310.9万美元,同比去年增长-60.16%
|
| 2016-05-10 |
详情>>
业绩披露：
2016年一季报每股收益-0.15美元,归母净利润-1040.8万美元,同比去年增长-64.35%
|
| 2016-04-14 |
股东大会：
将于2016-05-17召开股东大会
会议内容 ▼▲
- 1. to elect seven directors named in the accompanying proxy statement;
2. to approve the Third Amendment and Restatement of our 2002 Equity Incentive Plan to, among other items, increase the aggregate number of shares of our common stock that may be issued under such plan by 1,000,000 shares;
3. to hold an advisory vote to approve named executive officer compensation (“say-on-pay”);
4. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
5. to transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2016-02-22 |
详情>>
业绩披露：
2015年年报每股收益0.56美元,归母净利润3899.70万美元,同比去年增长-32.01%
|
| 2015-11-09 |
股东大会：
将于2015-12-08召开股东大会
会议内容 ▼▲
- 1.to vote upon a proposal to amend Article Fourth of the Company’s Restated Certificate of Incorporation to increase the authorized number of shares of the Company’s common stock, par value $0.01 per share, from 90,000,000 shares to 150,000,000 shares (the “Amendment”);
2.to transact such other business as may properly come before the Special Meeting or any postponement or adjournment thereof.
|
| 2015-04-14 |
股东大会：
将于2015-05-12召开股东大会
会议内容 ▼▲
- 1. to elect nine directors named in the accompanying proxy statement;
2. to hold an advisory vote to approve named executive officer compensation (“say-on-pay”);
3. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2015;
4. to transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2014-04-15 |
股东大会：
将于2014-05-13召开股东大会
会议内容 ▼▲
- 1. to elect eight directors named in the accompanying proxy statement;
2. to hold an advisory vote to approve named executive officer compensation (“say-on-pay”);
3. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2014;
4. to transact such other business as may properly come before the annual meeting or any postponement or adjournment thereof.
|
| 2013-04-15 |
股东大会：
将于2013-05-14召开股东大会
会议内容 ▼▲
- 1. to elect seven directors, as described in the accompanying proxy statement;
2. to approve the Second Amendment and Restatement of our 2002 Equity Incentive Plan to, among other items, increase the aggregate number of shares of our common stock that may be issued under such plan by 3.15 million shares;
3. to hold an advisory vote to approve named executive officer compensation (“say-on-pay”);
4. to ratify the appointment of KPMG LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2013;
5. to transact such other business as may properly come before the annual meeting or any postponement or adjournment thereof.
|